This page shows the latest Therapeutic vaccines news and features for those working in and with pharma, biotech and healthcare.
CureVac’s candidate, like other investigational vaccines from Pfizer and BioNTech and Moderna, uses mRNA technology, which is a relatively new research area. ... The hope is that by using mRNA technology to develop vaccines and therapeutic treatments,
mRNA technology has been in the spotlight during the race to develop a COVID-19 vaccine, with a number of companies utilising this research area to develop innovative vaccines for the ... The hope is that by using mRNA technology to develop vaccines and
collaboration focused on the development of mRNA-based vaccines and monoclonal antibodies (mAbs). ... The hope is that by using mRNA technology to develop vaccines and therapeutic treatments, specific proteins and antigens can be produced by the body’s
said Johan Van Hoof, global therapeutic area head, vaccines and managing director, Janssen vaccines &prevention. ... Meanwhile, J&J and Merck are now looking to gain official regulatory approvals for their Ebola vaccines with global healthcare agencies.
In April, Leaps by Bayer made an undisclosed investment in US-based biotech Khloris Biosciences, which specialises in using iPSCs as prophylactic and therapeutic vaccines, using them as a vehicle to
The AMR Industry Alliance said urgent action is needed to address economic challenges to R&D in areas such as antibiotics, vaccines, diagnostics and therapeutic agents.
More from news
Approximately 0 fully matching, plus 27 partially matching documents found.
A partial revision to the Swiss Patents Act and its implementing provisions came into force on 1 January 2019, together with an ordinary revision of the Therapeutic Products Act. ... For example, over the last five years, Lundbeck acquired Prexton
You have a broad pipeline of candidates, including therapeutic vaccines, such as your vaccine for prostate cancer in phase 1. ... How big a role do you think therapeutic vaccines will play in future cancer treatment?
Researchers are now trying to identify biomarker-based subgroups and drug combinations to try to improve therapeutic outcomes for patients. ... Vaccines. While the first therapeutic cancer vaccines have reached the market, eg Dendreon’s Provenge and
Exclusive licence. 522. AC Immune/ Janssen. To develop and commercialise therapeutic anti-Tau vaccines [ACI35, P1] for the treatment of Alzheimer's disease. ... 3 year research collaboration and exclusive licence. 509. Neuropore Therapies/UCB. To develop
The deal brings to Mylan a portfolio of over 100 specialty and branded generic products in five major therapeutic areas (cardio-metabolic, gastrointestinal, anti-infective/respiratory, CNS/pain and women's ... Baxter forecasts that its revenues from
More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.
At Cambridge, US-based Neon he will be tasked with guiding the immuno-oncology company's research programmes, which are focused on developing neoantigen-based therapeutic vaccines and T cell therapies.
Together, they bring a wealth of experience to advance therapeutic vaccines for Bionor, and specifically will add operational strength to get our HIV functional cure approach advanced to patients and the
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...